netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Abemaciclib found 7 matches

Open monograph to display formulary status BNF Category
  Abemaciclib  (Verzenios) Malignant disease and immunosuppression - Breast cancer - 08.03.04.01
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (June 2021): CDK4/6 inhibitors (abemaciclib▼, palbociclib▼, ribociclib▼): reports of interstitial lung disease and pneumonitis, including severe cases (08.03.04.01)
link in drug section MHRA Drug Safety Update (June 2021): CDK4/6 inhibitors (abemaciclib▼, palbociclib▼, ribociclib▼): reports of interstitial lung disease and pneumonitis, including severe cases (08.03.04.01)
link in drug section MHRA Drug Safety Update (June 2021): CDK4/6 inhibitors (abemaciclib▼, palbociclib▼, ribociclib▼): reports of interstitial lung disease and pneumonitis, including severe cases (08.03.04.01)
link in drug section NICE TA 563: Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer (08.03.04.01)
link in drug section NICE TA725: Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy (08.03.04.01)
link in drug section NICE TA810: Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence (08.03.04.01)


 

netFormulary